Dr. Thant Zin, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 310 2nd Ave Sw, 107-a, Miami, OK 74354 Phone: 918-540-7820 Fax: 918-540-7819 |
Romeo Lapus Obsequio, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 310 2nd Ave Sw Ste 105, Miami, OK 74354 Phone: 918-542-5551 Fax: 918-542-1555 |
Dr. Su Su Lin, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 310 2nd Ave Sw, Ste. 107-a, Miami, OK 74354 Phone: 918-540-7820 Fax: 918-540-7819 |
News Archive
Roche announced today the acquisition of Signature Diagnostics AG, a privately held company based in Potsdam, Germany. Signature is a translational oncology and genomics company that develops large blood plasma and tissue biobanks in multiple cancers, including colorectal and lung, which are constructed from multicenter prospective clinical studies.
Ceelox, Inc. proudly announced today that it was issued a patent from the U.S. Patent Office. The patent, U.S. Patent Number 7,945,520 entitled "System and Method for Secure and/or Interactive Dissemination of Information," provides the ability for associating message content with a media element, such as an advertisement, sending the message to a designated recipient, and presenting the media content only after the "unwrapping" of the message through the use of biometric authentication.
Dementia is a leading cause of death in the United States; however, patients dying with this disease may not receive optimal end-of-life care. ... many of these [nursing home] residents commonly experience burdensome and costly interventions, such as hospital transfers, tube-feeding, and intravenous antibiotics. ... Nursing home reimbursement policies are among the factors that incentivize more aggressive care. ... This study linked unique prospective clinical data with Medicare claims to describe and compare patterns of care between nursing home residents with advanced dementia enrolled in a Medicare managed-care insurance plan and those with fee-for-service Medicare.
Alliqua, Inc., an advanced biomedical products company focused on the development and manufacturing of proprietary drug delivery and wound care technologies today announced that it has acquired from Noble Biomaterials, Inc. a 10 year exclusive global license for two wound care dressings, with an additional 10 year renewal option.
With a lack of effective treatments for Alzheimer's, most of us would think long and hard about whether we wanted to know years in advance if we were genetically predisposed to develop the disease. For researchers, however, such knowledge is a window into Alzheimer's disease's evolution.
› Verified 8 days ago